Adult Nodular Sclerosis Hodgkin Lymphoma Active Not Recruiting Phase 1 Trials for Bendamustine (DB06769)

IndicationStatusPhase
DBCOND0030887 (Adult Nodular Sclerosis Hodgkin Lymphoma)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02168140CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin LymphomaTreatment